These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 83671)

  • 21. Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals.
    Martin R; Jaraquemada D; Flerlage M; Richert J; Whitaker J; Long EO; McFarlin DE; McFarland HF
    J Immunol; 1990 Jul; 145(2):540-8. PubMed ID: 1694881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of association with the CD28/CTLA4/ICOS gene region among Norwegian multiple sclerosis patients.
    Lorentzen AR; Celius EG; Ekstrøm PO; Wiencke K; Lie BA; Myhr KM; Ling V; Thorsby E; Vartdal F; Spurkland A; Harbo HF
    J Neuroimmunol; 2005 Sep; 166(1-2):197-201. PubMed ID: 16005527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. Complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones.
    Meinl E; Weber F; Drexler K; Morelle C; Ott M; Saruhan-Direskeneli G; Goebels N; Ertl B; Jechart G; Giegerich G
    J Clin Invest; 1993 Dec; 92(6):2633-43. PubMed ID: 7504690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A linkage analysis of the Gm locus and multiple sclerosis.
    Haile RW; Goldstein A; Field L; Marazita ML
    Genet Epidemiol; 1985; 2(1):29-34. PubMed ID: 3876966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [HLA and familial multiple sclerosis].
    Barroche G; Perrier P; Raffoux C; Gehin P; Streiff F; Weber M
    Rev Neurol (Paris); 1986; 142(10):738-45. PubMed ID: 3823705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.
    Lorentzen AR; Karlsen TH; Olsson M; Smestad C; Mero IL; Woldseth B; Sun JY; Senitzer D; Celius EG; Thorsby E; Spurkland A; Lie BA; Harbo HF
    Ann Neurol; 2009 Jun; 65(6):658-66. PubMed ID: 19630074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Familial multiple sclerosis: clinical, histocompatibility, and viral serological studies.
    Eldridge R; McFarland H; Sever J; Sadowsky D; Krebs H
    Ann Neurol; 1978 Jan; 3(1):72-80. PubMed ID: 418737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple sclerosis immunopathic trait and HLA-DR(2)15 as independent risk factors in multiple sclerosis.
    Callander M; Haghighi S; Landtblom AM; Ahlgren CE; Nilsson SI; Rydberg L; Al Khoury H; Rosegren L; Andersen O
    Mult Scler; 2007 May; 13(4):441-5. PubMed ID: 17463066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The HLA system and multiple sclerosis].
    Lu W; Zhao BX
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1987 Aug; 20(4):205-7. PubMed ID: 3501977
    [No Abstract]   [Full Text] [Related]  

  • 30. [HLA, A, B and DR in 20 patients with multiple sclerosis].
    Burguera JA; Montoro JA; Coret F; Soler MA; Blasco R; López Arlandis J
    Arch Neurobiol (Madr); 1988; 51(5):278-81. PubMed ID: 3219022
    [No Abstract]   [Full Text] [Related]  

  • 31. [A focus of multiple sclerosis in Bretagne: HLA markers and evaluation of consanguinity].
    Edan G; Madigand M; Merienne M; Morel G; Sabouraud O; Salmon D; Semana G; Fauchet R
    Rev Neurol (Paris); 1991; 147(8-9):595-9. PubMed ID: 1962069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Multiple sclerosis and psoriasis].
    Cendrowski W
    Wiad Lek; 1989 May; 42(9):575-8. PubMed ID: 2629326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphocytotoxic antibody in multiple sclerosis: activity against T cell subsets and correlation with disease activity.
    Scott CF; Spitler LE
    Clin Exp Immunol; 1983 Jul; 53(1):133-9. PubMed ID: 6223730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinico-immunologic parallels in multiple sclerosis].
    Prokof'ev VF; Konenkov VI; Gribacheva IA; Voronova IA; Doronin BM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(2):31-4. PubMed ID: 2728717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HLA-DR antigens in Black North-Americans and their association with HLA-D.
    Duquesnoy RJ; Marrari M; Annen K; Pollack MS; Dupont B
    Tissue Antigens; 1979 Aug; 14(2):145-56. PubMed ID: 91224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Histocompatibility antigens in multiple sclerosis in children].
    Efimenko VN; Evtushenko SK; Khodakovskiĭ AV
    Lik Sprava; 1998 Aug; (6):67-9. PubMed ID: 9844877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B-lymphocyte alloantigens associated with multiple sclerosis.
    Compston DA; Batchelor JR; McDonald WI
    Lancet; 1976 Dec; 2(7998):1261-5. PubMed ID: 63743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A "spontaneous" cold-reactive IgM antibody with anti HLA-B8 specificity in a patient with multiple sclerosis.
    Lenhard V; Diehm H; Römer W; Rauterberg EW; Kownatzki E; Roelcke D
    Immunobiology; 1982 Feb; 160(5):382-91. PubMed ID: 6175560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA-D typing in multiple sclerosis: Israelis tested with European homozygous typing cells.
    Brautbar C; Amar A; Cohen N; Oksenberg J; Cohen I; Kahana E; Bloch D; Alter M; Grosse-Wilde H
    Tissue Antigens; 1982 Mar; 19(3):189-97. PubMed ID: 6953617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Class II HLA antigens in patients with multiple sclerosis from Warsaw and Gdansk regions].
    Fryze W; Członkowska A; Bieganowska K; Kłos M; Nowak J; Obiedziński R; Szirkowiec W
    Neurol Neurochir Pol; 1997; 31(2):229-36. PubMed ID: 9380253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.